Stifel maintains Hold on Sionna Therapeutics stock at $7 target
At a glance
- $SION today−1.60%last $3.07
- Vs industry peers−0.75 pts6-peer median −0.85% · behind
- Since Sep 15−55.4%from the first trade after the story
- 52-week range2.7% above low$2.99 – $54.97
- Cash runway~12 mo$83.9M cash ÷ $7.0M/mo burn · 10-Q
- In the headline$7Amount
Nothing reported about sionna across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: This one turns on a concrete figure ($7); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $SION -1.60% in the latest session.
- Timing: It came out pre-market, so the next session was the first that could react.
Where the stock stands
Sionna Therapeutics ($SION) declined 1.60% to $3.07 in the latest session. Over the past month it is down 23.4%. That leaves it 94% below its 52-week high of $54.97 and 2.7% above its low of $2.99, close to the bottom of its range. The year's high was 18.4 times its low, which makes double-digit swings fairly routine here.
What the filings say
In its latest report (10-Q, filed Nov 10, 2026), $SION lost $32.4M over the quarter to Sep 30, 2026. Operations used $62.8M of cash over the nine months to Sep 30, 2026 — about $7.0M a month — against $83.9M in cash on Sep 30, 2026. At that pace the cash covers about 12 months, which is why financing, asset sales or restructuring tend to come up for companies in this position. Total liabilities were $22.7M against $83.9M of cash on Sep 30, 2026. The company filed an 8-K — the form for material events — on Sep 14, 1 day before this story; it is $SION's own account and the first thing to read. Figures are as filed with the SEC; the $SION page has the full statements.
How much coverage it is getting
Nothing new on Sionna Therapeutics has come through Wook's feeds in the last 30 days, so this is still the most recent story on it.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Wook's supply-chain scanner shows no unusual stress in Health Care today.
What to watch next
The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $SION page, and they say what management has disclosed without a reporter in between. Where several outlets agree is usually the news; where they differ is the angle. Wook AI, at the top of the page, can work out how far $SION is from its high or compare this week's coverage with earlier weeks.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on September 15, 2026. $SION has moved -55.38% ($6.88 to $3.07). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
